Home  »  Stock   »  Seres Therapeutics Inc.: A Year of Highs, Lows, an...

Seres Therapeutics Inc.: A Year of Highs, Lows, and Market Resilience

The stock price for Seres Therapeutics Inc. (MCRB) currently stands at $4.74. The stock experienced a substantial increase in the last session, hitting $5.1099 after starting at $4.91. The stock’s lowest price was $4.88 before closing at $5.05.

Seres Therapeutics Inc. saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $9.49 on 11/01/22, while the lowest price for the same duration was marked at $2.50 on 06/16/22.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


52-week price history of MCRB Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Seres Therapeutics Inc.’s current trading price is -50.00% away from its 52-week high, while its distance from the 52-week low is 89.80%. The stock’s price range during this period has spanned from $2.50 to $9.49. In the Healthcare sector, the Seres Therapeutics Inc.’s shares surpassed a trading volume of approximately 0.97 million for the day, which was noticeably lower compared to the average daily volume of 9.2.87 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Seres Therapeutics Inc. (MCRB) has experienced a quarterly decline of -8.40% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 644.58M and boasts a workforce of 431 employees.

A Closer Look at Analysts’ Ratings for Seres Therapeutics Inc.

As of right now, 6 analysts are rating Seres Therapeutics Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.47, with a change in price of -0.88. Similarly, Seres Therapeutics Inc. recorded 2,051,804 in trading volume during the last 100 days, posting a change of -15.60%.

MCRB Stock Stochastic Average

Today’s raw stochastic average for Seres Therapeutics Inc. over the last 50 days is 9.53%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 10.51%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 18.07% and 17.69%, respectively.

MCRB Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price decrease of -15.27%. However, over the past six months, we’ve seen a stronger performance of -27.00%. The price of MCRB leaped by -22.97% over the last 30 days. And in the last five days, it has fallen by -3.75%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts